These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9333029)

  • 1. Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection.
    Mattie H; Zhang LC; van Strijen E; Sekh BR; Douwes-Idema AE
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2083-8. PubMed ID: 9333029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model.
    Grossi O; Caillon J; Arvieux C; Jacqueline C; Bugnon D; Potel G; Hamel A
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3401-3. PubMed ID: 17576849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.
    Murillo O; Pachón ME; Euba G; Verdaguer R; Carreras M; Cabellos C; Cabo J; Gudiol F; Ariza J
    J Antimicrob Chemother; 2009 Nov; 64(5):1062-6. PubMed ID: 19744977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    El Haj C; Murillo O; Ribera A; Vivas M; Garcia-Somoza D; Tubau F; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5576-80. PubMed ID: 24957833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.
    Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Glupczynski Y; Tulkens PM
    Antimicrob Agents Chemother; 2007 May; 51(5):1627-32. PubMed ID: 17307986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML; de Górgolas M
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical dose effect of continuously administered cloxacillin in treatment of tolerant Staphylococcus aureus endocarditis in rats.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
    J Antimicrob Chemother; 1994 Mar; 33(3):585-93. PubMed ID: 8040122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro study of several pharmacodynamic effects of meropenem.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Scand J Infect Dis; 1995; 27(5):469-74. PubMed ID: 8588137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.
    Sandberg A; Jensen KS; Baudoux P; Van Bambeke F; Tulkens PM; Frimodt-Møller N
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2391-400. PubMed ID: 20308386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cloxacillin-susceptible Staphylococcus aureus with high MIC to glycopeptides. Ever we use cloxacillin?].
    Morales-Cartagena A; Lalueza A; San Juan R; Aguado JM
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():25-9. PubMed ID: 26365730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer W; Broeders PH; Michel MF
    J Infect Dis; 1991 Mar; 163(3):640-3. PubMed ID: 1995736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.
    Peetermans WE; Hoogeterp JJ; Hazekamp-van Dokkum AM; van den Broek P; Mattie H
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1869-74. PubMed ID: 2149812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
    Lepak AJ; Marchillo K; Craig WA; Andes DR
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
    Wolff M; Nercelles P; Pepay K
    Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
    [No Abstract]   [Full Text] [Related]  

  • 16. Penicillin (cloxacillin)-tolerant Staphylococcus aureus from bovine mastitis: identification and lack of correlation between tolerance in vitro and response to therapy in vivo.
    Craven N; Anderson JC; Wilson CD
    Res Vet Sci; 1983 May; 34(3):266-71. PubMed ID: 6878877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis.
    Voorn GP; Thompson J; Goessens WH; Schmall-Bauer W; Broeders PH; Michel MF
    J Infect Dis; 1992 Jul; 166(1):169-73. PubMed ID: 1607692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
    Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
    Kaczmarska L; Jakoniuk P
    Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.